# Fujifilm Diosynth Biotechnologies to expand Holly Springs biopharma plant with $1.2B investment

Fujifilm Diosynth Biotechnologies announced a $1.2 billion expansion of its biopharmaceutical manufacturing plant in Holly Springs, North Carolina, adding 680 jobs. The expansion is expected to come online early in 2028.

- Type: Expansion
- Announced: 2024-04-11
- Where: Holly Springs, North Carolina, United States
- Value: $1.20B
- Jobs: 680
- Starts operating: 2028
- Status: announced
- Products: biopharmaceuticals, cell culture facility
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Fujifilm Diosynth Biotechnologies](https://endata.com/companies/66246.md)
- [Fujifilm](https://endata.com/companies/5880.md) (partner)

## Sources

- [kioncentralcoast.com](https://kioncentralcoast.com/ap-national/2024/04/11/on-eve-of-japanese-prime-ministers-visit-to-north-carolina-fujifilm-announces-more-jobs-there-2/), 2024-04-11: "The new jobs are on top of the 725 announced by the subsidiary when the initial $2 billion investment was announced in March 2021."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.